United Therapeutics (UTHR) Sales of Property, Plant and Equipment (2017)
Powered by 
Analysis
United Therapeutics (UTHR) Sales of Property, Plant and Equipment (2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 63.00 Mn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | - |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 26.00 Mn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 363.82 Mn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | - |